A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The main objective of this trial is to evaluate the safety and immunogenicity of mRNA-1189 after intradermal and intramuscular delivery.
Epistemonikos ID: 9de2693c48fb3c33230081e599b57be68478c7e8
First added on: Mar 19, 2026